This Single Nvidia Policy Keeps Me Hitting The Buy Button

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • NVDA's quarterly dividend jumped 25x and a fresh $80 billion buyback joins $39 billion already authorized, returning $41 billion to shareholders in FY2026.

  • NVDA's 101% ROE and 92% Data Center growth tower over AMD and AVGO, and even AMZN's Trainium still runs alongside NVIDIA hardware inside AWS.

  • China H20 shipments dropped to zero from $4.6 billion a year ago, yet $119 billion in supply commitments show outside demand absorbs everything NVIDIA ships.

  • Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

This Single Nvidia Policy Keeps Me Hitting The Buy Button

© BenBen Lam via YouTube

I keep hitting the buy button on NVIDIA because of one policy decision, and I want to be blunt about it: the 25x quarterly dividend jump from $0.01 to $0.25 paired with a fresh $80 billion buyback authorization on top of the roughly $39 billion still remaining is the single clearest signal a management team can send a long-term holder. That is a company telling me it plans to route a large slice of its cash directly into my account for years, not a token gesture.

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) is the position I keep adding to, and the capital return program is the anchor. In Q1 FY27 alone, roughly $20.0 billion went back to shareholders through repurchases and dividends. Across FY2026, the company returned $41.1 billion ($40.1B in buybacks plus $974M in dividends). That is real capital, coming out of real cash flow, hitting the float every quarter.

The Cash Behind the Policy

A buyback promise only matters if the cash exists to fund it. Here, the cash is not in doubt. FY2026 operating cash flow hit $102.7 billion and free cash flow reached $96.7 billion, with CapEx running at roughly 6% of operating cash flow. Ninety-four cents of every operating dollar is available for shareholders or reinvestment. In the most recent quarter, non-GAAP gross margin ran at 75.0%, up from 60.8% a year earlier, and revenue grew 85.23% year over year to $81.615 billion. Q2 FY27 guidance points to $91.0 billion in revenue. The balance sheet carries debt/equity of 0.073 and interest coverage of 503x. That is the profile of a company that can keep the policy running.

Why Not the Obvious Alternatives

Readers reach first for Advanced Micro Devices (NASDAQ:AMD), Broadcom (NASDAQ:AVGO), or Amazon (NASDAQ:AMZN) with its Trainium chip. I have looked. None of them are running Data Center revenue of $75.246 billion at 92% YoY growth, or Data Center Networking at $14.8 billion growing 199%. NVIDIA’s ROE of 101.5% and ROIC of 92.2% tower over what AMD or Broadcom post. Amazon’s Trainium is a multibillion-dollar business, real competition, but Amazon itself deploys NVIDIA in AWS at scale. If we are talking about a chip supplier returning cash while growing 85.2% on an $81.61B revenue base, there is one name. (For readers exploring the broader picture, 24/7 Wall St. has a useful primer on stocks powering the AI buildout.)

The Real Risk

China is the risk I do not wave away. Q1 FY27 saw zero H20 shipments to China, versus $4.6 billion in the year-ago quarter, and Q2 guidance assumes no China Data Center compute revenue at all. Losing that market is a real hole. It has not changed my thesis because the company grew Data Center revenue 92% anyway, and total supply commitments of $119.0 billion tell me the demand outside China is absorbing everything NVIDIA can ship.

What Keeps the Buy Button Active

When a business generating $96.7 billion in free cash flow commits roughly $119 billion of authorized capital to shrinking its own share count, every share I hold gets a slightly larger claim on future earnings without me lifting a finger. That is the compounding engine I want in a retirement account, and it is why my next buy order is already written.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

CHRW Vol: 706,235
WMB Vol: 4,348,136
SJM Vol: 1,390,968
ANET Vol: 2,191,380
F5
FFIV Vol: 159,174

Top Losing Stocks

CTRA Vol: 73,319,495
MRNA Vol: 13,914,003
BSX Vol: 20,643,041
GDDY Vol: 1,041,585
INTU Vol: 7,281,168